These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16843671)

  • 1. Molecular docking study and development of an empirical binding free energy model for phosphodiesterase 4 inhibitors.
    Oliveira FG; Sant'Anna CM; Caffarena ER; Dardenne LE; Barreiro EJ
    Bioorg Med Chem; 2006 Sep; 14(17):6001-11. PubMed ID: 16843671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for a reliable orientation of ligands in their binding site: comparison between a structure-based (Glide) and a ligand-based (FIGO) approach in the case study of PDE4 inhibitors.
    Gratteri P; Bonaccini C; Melani F
    J Med Chem; 2005 Mar; 48(5):1657-65. PubMed ID: 15743207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective docking study of PDE4B ligands and an analysis of the behavior of selected scoring functions.
    Mpamhanga CP; Chen B; McLay IM; Ormsby DL; Lindvall MK
    J Chem Inf Model; 2005; 45(4):1061-74. PubMed ID: 16045302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Venkatarangan P; Hopfinger AJ
    J Med Chem; 1999 Jun; 42(12):2169-79. PubMed ID: 10377222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of small-sized libraries by combinatorial assembly of linkers and functional groups to a given scaffold: application to the structure-based optimization of a phosphodiesterase 4 inhibitor.
    Krier M; Araújo-Júnior JX; Schmitt M; Duranton J; Justiano-Basaran H; Lugnier C; Bourguignon JJ; Rognan D
    J Med Chem; 2005 Jun; 48(11):3816-22. PubMed ID: 15916433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
    Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
    Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.
    Xu RX; Rocque WJ; Lambert MH; Vanderwall DE; Luther MA; Nolte RT
    J Mol Biol; 2004 Mar; 337(2):355-65. PubMed ID: 15003452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
    Castro A; Jerez MJ; Gil C; Martinez A
    Med Res Rev; 2005 Mar; 25(2):229-44. PubMed ID: 15514991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides.
    Anderson AJ; Nicholson JM; Bakare O; Butcher RJ; Wilson TL; Scott KR
    Bioorg Med Chem; 2006 Feb; 14(4):997-1006. PubMed ID: 16219468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
    Zhou Z; Bates M; Madura JD
    Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen phosphorylase inhibitors: a free energy perturbation analysis of glucopyranose spirohydantoin analogues.
    Archontis G; Watson KA; Xie Q; Andreou G; Chrysina ED; Zographos SE; Oikonomakos NG; Karplus M
    Proteins; 2005 Dec; 61(4):984-98. PubMed ID: 16245298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Pseudomonas aeruginosa deacetylase LpxC inhibitory activity of dual PDE4-TNFalpha inhibitors: a multiscreening approach.
    Kadam RU; Garg D; Chavan A; Roy N
    J Chem Inf Model; 2007; 47(3):1188-95. PubMed ID: 17458951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,1,3-Benzothiadiazine derivatives: synthesis and screening versus PDE4 enzyme.
    Tait A; Luppi A; Avallone R; Baraldi M
    Farmaco; 2005 Aug; 60(8):653-63. PubMed ID: 15963514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodology and problems of protein-ligand docking: case study of dihydroorotate dehydrogenase, thymidine kinase, and phosphodiesterase 4.
    Pospisil P; Kuoni T; Scapozza L; Folkers G
    J Recept Signal Transduct Res; 2002; 22(1-4):141-54. PubMed ID: 12503612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical assessment of the automated AutoDock as a new docking tool for virtual screening.
    Park H; Lee J; Lee S
    Proteins; 2006 Nov; 65(3):549-54. PubMed ID: 16988956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitors.
    Whitehead JW; Lee GP; Gharagozloo P; Hofer P; Gehrig A; Wintergerst P; Smyth D; McCoull W; Hachicha M; Patel A; Kyle DJ
    J Med Chem; 2005 Feb; 48(4):1237-43. PubMed ID: 15715490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
    Park H; Bhattarai BR; Ham SW; Cho H
    Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA.
    Rastelli G; Del Rio A; Degliesposti G; Sgobba M
    J Comput Chem; 2010 Mar; 31(4):797-810. PubMed ID: 19569205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase.
    Huai Q; Sun Y; Wang H; Macdonald D; Aspiotis R; Robinson H; Huang Z; Ke H
    J Med Chem; 2006 Mar; 49(6):1867-73. PubMed ID: 16539372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.